Probiotic cell-free supernatant as effective antimicrobials against Klebsiella pneumoniae and reduce antibiotic resistance development
International Microbiology · 2024
DOI: 10.1007/s10123-024-00575-x ↗Kurz gefasst
Fachartikel in der Zeitschrift International Microbiology, 2024. Verfasst von Anh Duy Do und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, 700000, Vietnam. daduy@ntt.edu.vn. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Probiotics, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
This study evaluated the antimicrobial activity, resistance development, and synergistic potential of cell-free supernatant (CFSs) derived from Levilactobacillus brevis (Lb-CFS) and Lactiplantibacillus plantarum (Lp-CFS) against Klebsiella pneumoniae. Both CFSs exhibited potent growth inhibition, with minimum inhibitory concentrations (MICs) of 128 μg/mL and 64 μg/mL for Lb-CFS and Lp-CFS, respectively, and demonstrated dose-dependent bactericidal activity, achieving complete bacterial eradication at minimum bactericidal concentrations (MBC) within 6 h. The CFSs suppressed the expression of virulence genes (galF, wzi, and manC) and biofilm formation in a dose-dependent manner. Synergistic interactions were observed when combining CFSs with antibiotics, resulting in 2- to fourfold reductions in antibiotic MICs and MBCs. Notably, adaptive evolution experiments revealed significantly slower resistance development in K. pneumoniae against CFSs (twofold MIC/MBC increase) compared to antibiotics (16- to 128-fold increase) after 21 days. Furthermore, CFS-adapted strains exhibited increased antibiotic susceptibility, while antibiotic-adapted strains displayed cross-resistance to multiple antibiotics. No cross-resistance occurred between Lb-CFS and Lp-CFS, suggesting distinct adaptive mechanisms. These findings highlight the potential of probiotic-derived CFSs as effective antimicrobials with a lower propensity for inducing rapid resistance compared to conventional antibiotics, suggesting their promise in combating multidrug-resistant infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, 700000, Vietnam. daduy@ntt.edu.vn.
- Department of Biotechnology, NTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, 700000, Vietnam.
Zitieren
APA
Do, A. D., Quang, H. P., & Phan, Q. K. (2024). Probiotic cell-free supernatant as effective antimicrobials against Klebsiella pneumoniae and reduce antibiotic resistance development. International Microbiology. https://doi.org/10.1007/s10123-024-00575-x
Vancouver
Do AD, Quang HP, Phan QK. Probiotic cell-free supernatant as effective antimicrobials against Klebsiella pneumoniae and reduce antibiotic resistance development. International Microbiology. 2024. doi:10.1007/s10123-024-00575-x
BibTeX
@article{Do2024,
author = {Do, Anh Duy and Quang, Hoa Pham and Phan, Quang Khai},
title = {Probiotic cell-free supernatant as effective antimicrobials against Klebsiella pneumoniae and reduce antibiotic resistance development},
journal = {International Microbiology},
year = {2024},
doi = {10.1007/s10123-024-00575-x}
}
EUVIMED